← All themes

Immunotherapy & Oncology

Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.

388 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
276	276 DELISTED Oncternal Therapeutics, Inc. Common Stock ONCT	1	0	0%	$75
277	277 DELISTED SpringWorks Therapeutics SWTX	1	0	0%	$47
278	278 DELISTED Terns Pharmaceuticals TERN	1	-316	-100%	$75.4K
279	TYME 279 DELISTED Tyme Technologies, Inc. Common Stock TYME	1	+1	–	$14.2K
280	ADAP 280 DELISTED Adaptimmune Therapeutics ADAP	0	-1	-100%	$0
281	CNTA 281 DELISTED Centessa Pharmaceuticals CNTA	0	-161	-100%	$0
282	GNCA 282 DELISTED Genocea Biosciences, Inc. GNCA	0	-1	-100%	–
283	283 DELISTED Galera Therapeutics, Inc. Common Stock GRTX	0	-1	-100%	$0
284	284 DELISTED IO Biotech IOBT	0	-12	-100%	$0
285	285 DELISTED Kezar Life Sciences KZR	0	-43	-100%	$0
286	286 DELISTED Mersana Therapeutics MRSN	0	-1	-100%	$0
287	287 DELISTED Merus MRUS	0	-1	-100%	$0
288	PRTC 288 DELISTED PureTech Health PRTC	0	-5	-100%	$0
289	ABP 289 DELISTED Abpro Holdings ABP	–	–	–	–
290	290 Advanced Biomed Inc ADVB $8.44M	–	–	–	–
291	291 DELISTED Affimed AFMD	–	–	–	–
292	AMAM 292 DELISTED Ambrx Biopharma Inc AMAM	–	–	–	–
293	APGN 293 DELISTED Apexigen, Inc. Common Stock APGN	–	–	–	–
294	ATNX 294 DELISTED Athenex, Inc. Common Stock ATNX	–	–	–	–
295	AVEO 295 DELISTED AVEO Pharmaceuticals, Inc. AVEO	–	–	–	–
296	AYLA 296 DELISTED Ayala Pharmaceuticals, Inc. Common Stock AYLA	–	–	–	–
297	BCEL 297 DELISTED Atreca, Inc. Class A Common Stock BCEL	–	–	–	–
298	BIOC 298 DELISTED Biocept, Inc. BIOC	–	–	–	–
299	BLCM 299 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	–	–	–	–
300	BLSM 300 BlossomHill Therapeutics BLSM $478M	–	–	–	–